메뉴 건너뛰기




Volumn 18, Issue 2, 2004, Pages 230-231

Topical cidofovir and cryotherapy - Combination treatment for recalcitrant molluscum contagiosum in a patient with HIV infection [7]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; DIPHENCYPRONE; PODOPHYLLOTOXIN;

EID: 1642343991     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00706.x     Document Type: Letter
Times cited : (24)

References (5)
  • 1
    • 0029164574 scopus 로고
    • Hyperfocal cryotherapy of multiple Molluscum contagiosum lesions in patients with the acquired immune deficiency syndrome
    • Bardenstein DS, Elmets C. Hyperfocal cryotherapy of multiple Molluscum contagiosum lesions in patients with the acquired immune deficiency syndrome. Opthalmol 1995; 102: 1031-1034.
    • (1995) Opthalmol. , vol.102 , pp. 1031-1034
    • Bardenstein, D.S.1    Elmets, C.2
  • 2
    • 0030612401 scopus 로고    scopus 로고
    • Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with Cidofovir
    • Meadows KP, Tyring SK, Pavia AT, Rallis TM. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with Cidofovir. Arch Dermatol 1997; 133: 987-990.
    • (1997) Arch. Dermatol. , vol.133 , pp. 987-990
    • Meadows, K.P.1    Tyring, S.K.2    Pavia, A.T.3    Rallis, T.M.4
  • 3
    • 0033879540 scopus 로고    scopus 로고
    • Topical cidofovir: A novel treatment for recalcitrant molluscum contagiosum in HIV-infected children
    • Toro JR, Wood L, Turner M. Topical cidofovir: A novel treatment for recalcitrant molluscum contagiosum in HIV-infected children. Arch Dermatol 2000; 136: 983-985.
    • (2000) Arch. Dermatol. , vol.136 , pp. 983-985
    • Toro, J.R.1    Wood, L.2    Turner, M.3
  • 4
    • 0029704912 scopus 로고    scopus 로고
    • Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova, pox- and adenovirus) infections
    • De Clercq E. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova, pox- and adenovirus) infections. Vehr K Acad Geneesskd Belg 1996; 58: 19-47.
    • (1996) Vehr. K. Acad. Geneesskd. Belg. , vol.58 , pp. 19-47
    • De Clercq, E.1
  • 5
    • 0034919835 scopus 로고    scopus 로고
    • Efficacy of cidofovir in an HIV infected patient with an acyclovir and foscarnet resistant herpes simplex virus infection
    • Saint-Leger E, Fillet AM, Malvy D, Rabanel B, Caumes E. Efficacy of cidofovir in an HIV infected patient with an acyclovir and foscarnet resistant herpes simplex virus infection. Ann Dermatol Venereol 2001; 128: 747-749.
    • (2001) Ann. Dermatol. Venereol. , vol.128 , pp. 747-749
    • Saint-Leger, E.1    Fillet, A.M.2    Malvy, D.3    Rabanel, B.4    Caumes, E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.